Compare NPCE & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPCE | CLDT |
|---|---|---|
| Founded | 1997 | 2009 |
| Country | United States | United States |
| Employees | N/A | 16 |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.6M | 597.5M |
| IPO Year | 2021 | N/A |
| Metric | NPCE | CLDT |
|---|---|---|
| Price | $16.09 | $13.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $18.33 | $11.00 |
| AVG Volume (30 Days) | 172.6K | ★ 389.3K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.13% |
| EPS Growth | ★ 29.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $99,986,000.00 | N/A |
| Revenue This Year | $0.90 | $2.94 |
| Revenue Next Year | $24.46 | N/A |
| P/E Ratio | ★ N/A | $610.21 |
| Revenue Growth | ★ 25.13 | N/A |
| 52 Week Low | $7.56 | $6.08 |
| 52 Week High | $19.60 | $13.64 |
| Indicator | NPCE | CLDT |
|---|---|---|
| Relative Strength Index (RSI) | 47.96 | 64.69 |
| Support Level | $15.42 | $6.26 |
| Resistance Level | $17.49 | $13.64 |
| Average True Range (ATR) | 0.88 | 0.33 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 22.09 | 83.02 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania, among others. Substantially all of the company's assets are held and operated by its operating partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. Chatham's revenue streams include room, food and beverage, and other. The room comprises the majority of its total revenue. Chatham's hotels operate under various brands, which include Hilton, Marriott, and Hyatt.